EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, Alberto Carturan, Guido Ghilardi, Puneeth Guruprasad, Ruchi P. Patel, Melody T. Tan, A. Padmanabhan, Jean Lemoine, Eugenio Fardella, Yunlin Zhang, Raymone Pajarillo, Linhui Chen, Ositadimma Ugwuanyi, Kelly Markowitz, Devora Delman, Mathew G. Angelos, Olga Shestova, Yusuke Isshiki, Tatiana Blanchard, Wendy Béguelin, Ari Melnick, Gerald P. Linette, Gregory L. Beatty, Beatriz M. Carreno, Ivan Cohen, Luca Paruzzo, Stephen J. Schuster, Marco Ruella
Topics & Concepts
Cancer immunotherapyAdoptive immunotherapyImmunotherapyEZH2Cancer researchAdoptive cell transferCancerImmunologyT cellBiologyMedicineImmune systemGeneEpigeneticsGeneticsCAR-T cell therapy researchImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers